Fig. 1

Flowchart of the study. ADAS, anti-drug antibody set; DLTS, dose-limiting toxicity set; EFS, efficacy set; FAS, full analysis set; PKCS, pharmacokinetic concentration set; PKPS, pharmacokinetic parameter set; SS, safety set